David Bunka PhD

Dave holds a Ph.D. in Molecular Biology from the University of Leeds and is a Geneticist by training. He spent 12 years developing high throughput automated aptamer selection methods at the University of Leeds. David has built up a solid international reputation in the field. Since 2003 David has isolated ~200 aptamers against a wide variety of targets including: small molecule antibiotics, food contaminants, disease associated proteins, several cancer associated cell-lines, viruses and patient tissue samples. Since joining the group officially in 2012 David had developed over 50 aptamers to various targets and has development several patentable process variations. David has authored several aptamer papers in peer reviewed journals, including 2 invited review articles and a book chapter in 2012 for the Royal Society of Chemistry entitled “therapeutic uses of nucleic acid aptamer conjugates”.